SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-050624
Filing Date
2022-09-19
Accepted
2022-09-19 18:54:00
Documents
2
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1619
2 EX-24 DOCUMENT attachment1.htm EX-24 2139
  Complete submission text file 0001209191-22-050624.txt   5369
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Rothera Mark (Reporting) CIK: 0001550424 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 221251676